The COVID-19 pandemic created unprecedented disruptions to routine health care in the
United States. Screening mammography, a cornerstone of breast cancer control and …

The COVID-19 pandemic has disrupted preventive care, including cancer screening.
Studies from the United States and Europe have shown that cancer screening dropped …

Background Routine screening mammography at two-year intervals is widely recommended
for the prevention and early detection of breast cancer for women who are 50 years+. Racial …

Abstract Background In the United States, breast cancer is the most commonly diagnosed
cancer and second leading cause of cancer death in women. Early detection through …

Background Access to breast screening mammogram services decreased during the COVID-
19 pandemic. Our objectives were to estimate: 1) the COVID-19 affected period, 2) the …

Disparities in screening mammography and barriers to accessing breast cancer screening
are most prevalent among racial/ethnic minority and low-income women. The significant …

Background The coronavirus disease 2019 (COVID-19) pandemic led to a near-total
cessation of mammography services in the United States in mid-March 2020. It is unclear if …

Background: Breast cancer screening in Ontario, Canada, was deferred during the first wave
of the COVID-19 pandemic, and a prioritization framework to resume services according to …

National estimates project COVID-19 negatively influenced cancer screening, leading to an
estimated deficit of 3.9 million breast cancer (BC) screenings among US adults. 1, 2 In San …

Mammography rates had stag-nated over recent years in the US, and then came COVID-19.
The pandemic put life on hold for many people, including their receipt of preventive care …